Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe) [Phase 2]
Phase 2 trial of nivolumab plus ipilimumab in patients with hypermutated cancers detected in blood (NIMBLe) was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors [Phase 1, Phase 2]
Phase Ib/II trial updates the combination of GT90001 with KN046 in solid tumors, with phase progression in early development.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CEP-9722 (PARP inhibitor) in solid tumors was terminated; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL [Phase 1, Phase 2]
Phase 1/2 trial update for CX-2029 in solid tumors and DLBCL completed; aims to identify safe and active dose levels.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors [Phase 1, Phase 2]
A phase 1/2 trial evaluating BLZ945 alone or with PDR001 in advanced solid tumors was terminated; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors [Phase 1, Phase 2]
Results from a Phase 1/2 study of INCB001158 in combination with chemotherapy for solid tumors, including biliary tract cancer and colorecta…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Participants With Solid Tumors [Phase 2]
Phase 2 trial evaluating a single dose of sotatercept (ACE-011) on red blood cell mass and plasma volume in participants with solid tumors w…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: M3541 in Combination With Radiotherapy in Solid Tumors [Phase 1]
Phase 1 trial of M3541 in combination with radiotherapy in solid tumors was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-21Clinical Trial Update: Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of dalutrafusp alfa (GS-1423) in participants with advanced solid tumors has been terminated after results were posted.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors [Phase 2]
Phase 2 trial evaluating romiplostim to prevent chemotherapy-induced low platelets in children and young adults with solid tumors; the study…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for SHR-A2009 in combination with other antitumor therapies in patients with advanced solid tumors (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating LY3022855 in combination with durvalumab or tremelimumab in advanced solid tumors has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients [Phase 1, Phase 2]
A clinical trial update for c610 Injection in advanced solid tumors across Phase 1 and Phase 2 stages; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors [Phase 2]
Phase 2 trial of KN026 in combination with KN046 in patients with HER2-positive solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors [Phase 1, Phase 2]
A Phase 1/2 study evaluating lenvatinib in combination with everolimus for pediatric patients with recurrent and refractory solid tumors, in…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL [Phase 1, Phase 2]
Clinical trial update for tazemetostat as a single agent and in combination in B-cell lymphomas and solid tumors completed with results post…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies [Phase 2]
Phase 2 clinical study of anetumab ravtansine in adults with solid tumors; the trial has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: A Study of Afatinib in Patients With Advanced Cancer With Changes in the HER Gene [Phase 2]
Phase 2 study evaluating afatinib in patients with advanced cancer exhibiting HER gene changes; study completed.
-
CLINICAL_TRIALS trial_result · 2023-07-14Clinical Trial Update: Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors [Phase 1, Phase 2]
Phase I/II study evaluating αPD1-MSLN-CAR T cells in MSLN-positive advanced solid tumors; status not disclosed in the provided snippet.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CAN04 in combination with various chemotherapy regimens for advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC [Phase 1, Phase 2]
Phase 1/2 trial updates for dose-escalation of RMC4630 with cobi in relapsed/refractory solid tumors and RMC4630 with osi in EGFR+ locally a…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects [Phase 1, Phase 2]
Phase 1/2 trial evaluating SRA737 in combination with gemcitabine with or without cisplatin in patients with advanced solid tumors; study st…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer [Phase 2]
Phase II trial update evaluating bevacizumab plus erlotinib in Krebs cycle altered cancer; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies [Phase 1, Phase 2]
Open-label Phase 1/2 dose-escalation/expansion study of INCB059872 in advanced malignancies, assessing safety and preliminary activity; the …
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H) [Phase 2]
Phase 2 trial comparing nivolumab plus ipilimumab vs nivolumab alone in patients with advanced or metastatic solid tumors with high tumor mu…